NGNE
Price
$38.60
Change
+$0.99 (+2.63%)
Updated
Sep 4 closing price
Capitalization
771.04M
79 days until earnings call
Intraday BUY SELL Signals
TSHA
Price
$5.60
Change
+$0.03 (+0.54%)
Updated
Sep 4 closing price
Capitalization
1.83B
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NGNE vs TSHA

NGNE vs TSHA Comparison Chart in %
loading
loading
View a ticker or compare two or three
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Nektar Therapeutics (NASDAQ:NKTR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO), Cel-Sci Corp (ASE:CVM).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.33B. The market cap for tickers in the group ranges from 58 to 138.42B. VRTX holds the highest valuation in this group at 138.42B. The lowest valued company is SEELQ at 58.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was -0%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 2,397%. ONCO experienced the highest price growth at 67%, while VBIO experienced the biggest fall at -96%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 16%. For the same stocks of the Industry, the average monthly volume growth was -6% and the average quarterly volume growth was -0%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 78
Price Growth Rating: 53
SMR Rating: 94
Profit Risk Rating: 92
Seasonality Score: -10 (-100 ... +100)

Market Cap

The average market capitalization across the group is 1.3B. The market cap for tickers in the group ranges from 771.04M to 1.83B. TSHA holds the highest valuation in this group at 1.83B. The lowest valued company is NGNE at 771.04M.

High and low price notable news

The average weekly price growth across all stocks in the group was 1%. For the same group, the average monthly price growth was -3%, and the average quarterly price growth was 48%. NGNE experienced the highest price growth at 6%, while TSHA experienced the biggest fall at -3%.

Volume

The average weekly volume growth across all stocks in the group was 36%. For the same stocks of the group, the average monthly volume growth was 13% and the average quarterly volume growth was 23,613%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 99
Price Growth Rating: 40
SMR Rating: 98
Profit Risk Rating: 93
Seasonality Score: 22 (-100 ... +100)
VS
NGNE vs. TSHA commentary
Sep 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NGNE is a Hold and TSHA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 05, 2026
Stock price -- (NGNE: $38.60 vs. TSHA: $5.60)
Brand notoriety: NGNE and TSHA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NGNE: 77% vs. TSHA: 84%
Market capitalization -- NGNE: $771.04M vs. TSHA: $1.83B
NGNE [@Biotechnology] is valued at $771.04M. TSHA’s [@Biotechnology] market capitalization is $1.83B. The market cap for tickers in the [@Biotechnology] industry ranges from $138.42B to $0. The average market capitalization across the [@Biotechnology] industry is $2.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

TSHA’s FA Score shows that 0 FA rating(s) are green whileNGNE’s FA Score has 0 green FA rating(s).

  • TSHA’s FA Score: 0 green, 5 red.
  • NGNE’s FA Score: 0 green, 5 red.
According to our system of comparison, both TSHA and NGNE are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NGNE’s TA Score shows that 2 TA indicator(s) are bullish while TSHA’s TA Score has 1 bullish TA indicator(s).

  • NGNE’s TA Score: 2 bullish, 5 bearish.
  • TSHA’s TA Score: 1 bullish, 7 bearish.
According to our system of comparison, NGNE is a better buy in the short-term than TSHA.

Price Growth

NGNE (@Biotechnology) experienced а +5.52% price change this week, while TSHA (@Biotechnology) price change was -2.95% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.22%. For the same industry, the average monthly price growth was +5.23%, and the average quarterly price growth was +2396.59%.

Reported Earning Dates

NGNE is expected to report earnings on Nov 23, 2026.

TSHA is expected to report earnings on Nov 10, 2026.

Industries' Descriptions

@Biotechnology (-0.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TSHA($1.83B) has a higher market cap than NGNE($771M). NGNE YTD gains are higher at: 87.379 vs. TSHA (1.818). NGNE has higher annual earnings (EBITDA): -95.45M vs. TSHA (-128.67M). TSHA has more cash in the bank: 277M vs. NGNE (243M). NGNE has less debt than TSHA: NGNE (9.54M) vs TSHA (68.6M). TSHA has higher revenues than NGNE: TSHA (7.47M) vs NGNE (0).
NGNETSHANGNE / TSHA
Capitalization771M1.83B42%
EBITDA-95.45M-128.67M74%
Gain YTD87.3791.8184,806%
P/E RatioN/A2.70-
Revenue07.47M-
Total Cash243M277M88%
Total Debt9.54M68.6M14%
FUNDAMENTALS RATINGS
TSHA vs NGNE: Fundamental Ratings
TSHA
NGNE
OUTLOOK RATING
1..100
5891
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
56
Fair valued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
4436
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
5090

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NGNE's Valuation (56) in the null industry is in the same range as TSHA (62). This means that NGNE’s stock grew similarly to TSHA’s over the last 12 months.

NGNE's Profit vs Risk Rating (87) in the null industry is in the same range as TSHA (100). This means that NGNE’s stock grew similarly to TSHA’s over the last 12 months.

NGNE's SMR Rating (98) in the null industry is in the same range as TSHA (99). This means that NGNE’s stock grew similarly to TSHA’s over the last 12 months.

NGNE's Price Growth Rating (36) in the null industry is in the same range as TSHA (44). This means that NGNE’s stock grew similarly to TSHA’s over the last 12 months.

TSHA's P/E Growth Rating (98) in the null industry is in the same range as NGNE (100). This means that TSHA’s stock grew similarly to NGNE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NGNETSHA
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
87%
MACD
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
88%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 9 days ago
86%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
NGNE
Daily Signal:
Gain/Loss:
TSHA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSSIX29.74N/A
N/A
Principal SmallCap S&P 600 Index Inst
TRBIX31.28N/A
N/A
Nuveen Small Cap Blend Idx Retire
BSPAX900.94N/A
N/A
iShares S&P 500 Index Investor A
KMDVX35.06N/A
N/A
Keeley Gabelli Mid Cap Dividend A
SGIGX39.75N/A
N/A
Steward Global Equity Income Fund R6

NGNE and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, NGNE has been loosely correlated with BRNS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NGNE jumps, then BRNS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NGNE
1D Price
Change %
NGNE100%
+2.63%
BRNS - NGNE
51%
Loosely correlated
+5.50%
RCKT - NGNE
50%
Loosely correlated
+1.85%
RNAZ - NGNE
48%
Loosely correlated
-4.41%
TSHA - NGNE
46%
Loosely correlated
+0.54%
BCYC - NGNE
45%
Loosely correlated
+1.42%
More

TSHA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TSHA has been loosely correlated with NGNE. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TSHA jumps, then NGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TSHA
1D Price
Change %
TSHA100%
+0.54%
NGNE - TSHA
46%
Loosely correlated
+2.63%
PRME - TSHA
46%
Loosely correlated
-0.27%
MGTX - TSHA
44%
Loosely correlated
-0.57%
STOK - TSHA
43%
Loosely correlated
-0.60%
ABEO - TSHA
42%
Loosely correlated
+1.18%
More